“Efficacy and Safety of Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Trials by Race” (2026) SKIN The Journal of Cutaneous Medicine, 10(2), p. s769. doi:10.25251/e6gpah49.